Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
42.64
+2.43 (6.04%)
Jul 21, 2026, 1:27 PM EDT - Market open
Rapport Therapeutics Employees
Rapport Therapeutics had 84 employees as of December 31, 2025. The number of employees increased by 15 or 21.74% compared to the previous year.
Employees
84
Change (1Y)
15
Growth (1Y)
21.74%
Revenue / Employee
$238,095
Profits / Employee
-$1,277,107
Market Cap
2.04B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 84 | 15 | 21.74% |
| Dec 31, 2024 | 69 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| ADMA Biologics | 647 |
| AbCellera Biologics | 562 |
| Lakefront Biotherapeutics NV | 558 |
| Ocular Therapeutix | 325 |
| Nuvation Bio | 307 |
| Syndax Pharmaceuticals | 298 |
| UroGen Pharma | 298 |
| Viridian Therapeutics | 252 |
RAPP News
- 5 days ago - Rapport Therapeutics management to meet with Citizens - TheFly
- 20 days ago - Rapport Therapeutics Slides: Corporate presentation - Filings
- 27 days ago - Rapport Therapeutics initiated with an Outperform at Leerink - TheFly
- 4 weeks ago - Rapport Therapeutics management to meet with Citizens - TheFly
- 5 weeks ago - Rapport Therapeutics Transcript: AGM 2026 - Transcripts
- 6 weeks ago - Rapport Therapeutics Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 6 weeks ago - Rapport Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Rapport Therapeutics price target raised to $65 from $53 at BTIG - TheFly